XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Changes in Shareholders’ Deficit - USD ($)
Ordinary shares
Stock subscription receivable
Accumulated deficit
Total
Balance at Dec. 17, 2023 [1] $ 1,000 $ 10,000
Balance (in Shares) at Dec. 17, 2023 [1] 10,000      
Issuance of ordinary shares to founder $ 24,000 24,000
Issuance of ordinary shares to founder (in Shares) 1,715,000      
Stock subscription receivable (25,000) (25,000)
Allocation of offering costs to ordinary shares subject to possible redemption      
Accretion of carrying value to redemption value      
Subsequent remeasurement of ordinary shares subject to possible redemption      
Net income (loss) (3,680) (3,680)
Balance at Dec. 31, 2023 $ 25,000 (25,000) (3,680) $ (3,680)
Balance (in Shares) at Dec. 31, 2023 1,725,000     1,725,000 [2]
Capital contribution paid 25,000 $ 25,000
Sale of units in initial public offering, net of offering costs $ 57,159,797 57,159,797
Sale of units in initial public offering, net of offering costs (in Shares) 6,000,000      
Sale of units to the founder in private placement $ 2,500,000 2,500,000
Sale of units to the founder in private placement (in Shares) 250,000      
Initial classification of ordinary shares subject to possible redemption $ (56,232,427) (56,232,427)
Initial classification of ordinary shares subject to possible redemption (in Shares) (6,000,000)      
Allocation of offering costs to ordinary shares subject to possible redemption $ 2,661,858 2,661,858
Share forfeiture
Share forfeiture (in Shares) (225,000)      
Accretion of carrying value to redemption value $ (6,114,228) (615,203) (6,729,431)
Subsequent remeasurement of ordinary shares subject to possible redemption (789,076) (789,076)
Net income (loss) 502,638 502,638
Balance at Dec. 31, 2024 $ (905,321) $ (905,321)
Balance (in Shares) at Dec. 31, 2024 1,750,000     1,750,000 [2]
[1] On December 18, 2023 (date of inception), the Company issued 10,000 ordinary shares with no par value to the Sponsor.
[2] Includes up to an aggregate of 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. In November 2024, the underwriter did not exercise their 45-day option to purchase 900,000 Units, therefore 225,000 founder shares are subject to forfeiture.